Market Overview:

The peripheral vascular devices market is experiencing rapid growth, driven by rising disease prevalence, advancements in technology, and growing demand for minimally invasive procedures. According to IMARC Group’s latest research publication, “Peripheral Vascular Devices Market Report by Device Type (Peripheral Vascular Stents, Peripheral Transluminal Angioplasty (PTA) Balloon Catheters, Peripheral Transluminal Angioplasty (PTA) Guidewires, Atherectomy Devices, Embolic Protection Devices, Inferior Vena Cava Filters, and Others), End User (Hospitals and Clinics, Ambulatory Care Centers, Specialty Clinics, and Others), and Region 2025-2033“, The global peripheral vascular devices market size reached USD 12.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://www.imarcgroup.com/peripheral-vascular-devices-market/requestsample

Our report includes:

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Factors Affecting the Growth of the Peripheral Vascular Devices Industry:

• Rising Disease Prevalence

A key driver for this market is the increasing global incidence of peripheral vascular diseases (PVDs), including peripheral artery disease (PAD). The growing patient population is largely attributed to aging and the rising prevalence of diabetes, obesity, and sedentary lifestyles. The world is simply becoming an unhealthier place! As diabetic, chronic, and peripheral vascular events become more common, the demand for effective devices and kits to diagnose and treat PVDs, including stents, catheters, and angioplasty balloons will only increase, stimulating more devices and ultimately, newer devices.

• Advancements in Technology

Technological advancements are altering the peripheral vascular devices market landscape. The push for minimally invasive procedures, the introduction of drug-eluting stents, drug-coated balloons, and atherectomy devices are showing efficacy, while recovery times are shorter than traditional approaches. New imaging systems, and bioresorbable products, provide greater safety and treatment precision. There is an increasing appeal for healthcare providers and patients alike.

• Growing Demand for Minimally Invasive Procedures

Minimally invasive endovascular procedures have shifted preferences away from traditional open access surgeries. Minimally invasive option offers several benefits to patients and clinicians including smaller incisions, less pain, shorter hospital stay, and quicker recovery. In other words, this preference leads to increased demand for peripheral vascular devices for these types of advanced catheter-based procedures and has driven market growth.

Leading Companies Operating in the Global Peripheral Vascular Devices Industry:

• Abbott Laboratories
• B. Braun SE (B. Braun Holding GmbH & Co. KG)
• Becton, Dickinson and Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Group Incorporated
• Cordis Corporation
• iVascular S.L.U.
• Koninklijke Philips N.V.
• Medtronic plc
• Terumo Medical Corporation

Peripheral Vascular Devices Market Report Segmentation:

Breakup by Device Type:

• Peripheral Vascular Stents
• Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
• Peripheral Transluminal Angioplasty (PTA) Guidewires
• Atherectomy Devices
• Embolic Protection Devices
• Inferior Vena Cava Filters
• Others

The report provides a detailed overview and analysis of the market by device type. This includes peripheral vascular stents, peripheral transluminal angioplasty (PTA) balloon catheters, peripheral transluminal angioplasty (PTA) guidewires, atherectomy devices, embolic protection devices, inferior vena cava filters, and others. According to the report, peripheral vascular stents represent the largest segment.

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Care Centers
• Specialty Clinics
• Others

The report also provides a detailed overview and analysis of the market based on the end user. This includes hospitals and clinics, ambulatory care centers, specialty clinics, and others. According to the report, hospitals and clinics have the largest share in the market.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the market, accounting for the largest peripheral vascular devices market share

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145